Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $1.08 in the prior trading day, Tenaya Therapeutics Inc (NASDAQ: TNYA) closed at $1.1, up 1.85%. In other words, the price has increased by $1.85 from its previous closing price. On the day, 1.82 million shares were traded. TNYA stock price reached its highest trading level at $1.13 during the session, while it also had its lowest trading level at $1.08.
Ratios:
Our goal is to gain a better understanding of TNYA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.00 and its Current Ratio is at 6.00. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.09.
On June 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.H.C. Wainwright initiated its Buy rating on June 15, 2022, with a $25 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 18 ’25 when Higa Tomohiro sold 2,962 shares for $1.25 per share. The transaction valued at 3,711 led to the insider holds 95,338 shares of the business.
Tingley Whittemore sold 5,053 shares of TNYA for $6,331 on Aug 18 ’25. The Chief Medical Officer now owns 172,803 shares after completing the transaction at $1.25 per share. On Aug 18 ’25, another insider, Ali Faraz, who serves as the Chief Executive Officer of the company, sold 14,533 shares for $1.25 each. As a result, the insider received 18,210 and left with 302,792 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNYA now has a Market Capitalization of 179273600 and an Enterprise Value of 119816712.
Stock Price History:
The Beta on a monthly basis for TNYA is 3.07, which has changed by -0.6028881 over the last 52 weeks, in comparison to a change of 0.1590569 over the same period for the S&P500. Over the past 52 weeks, TNYA has reached a high of $4.01, while it has fallen to a 52-week low of $0.36. The 50-Day Moving Average of the stock is 39.71%, while the 200-Day Moving Average is calculated to be 1.57%.
Shares Statistics:
The stock has traded on average 3.02M shares per day over the past 3-months and 5919600 shares per day over the last 10 days, according to various share statistics. A total of 162.98M shares are outstanding, with a floating share count of 137.66M. Insiders hold about 15.53% of the company’s shares, while institutions hold 18.01% stake in the company. Shares short for TNYA as of 1755216000 were 11919989 with a Short Ratio of 3.95, compared to 1752537600 on 10199968. Therefore, it implies a Short% of Shares Outstanding of 11919989 and a Short% of Float of 20.09.
Earnings Estimates
Tenaya Therapeutics Inc (TNYA) is currently under the scrutiny of 7.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.07 and low estimates of -$0.18.
Analysts are recommending an EPS of between -$0.58 and -$0.75 for the fiscal current year, implying an average EPS of -$0.68. EPS for the following year is -$0.6, with 6.0 analysts recommending between -$0.51 and -$0.73.
